Primary familial hypertrophic cardiomyopathy: genes and variants
Explore variant evidence for Primary familial hypertrophic cardiomyopathy across 8 analyzed proteins (GLA, MYH7, ACTN2, MYBPC3, JPH2 and 3 more). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 408 variants of uncertain significance and 130 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Primary familial hypertrophic cardiomyopathy
GLA: Alpha-galactosidase A
It removes terminal alpha-galactose residues from glycosphingolipids during lysosomal degradation. Loss-of-function variants cause Fabry disease, with progressive accumulation of globotriaosylceramide-related lipids in vascular, renal, cardiac, and nervous tissues.
5 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in GLA have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
MYH7: Myosin-7
Its beta-myosin motor converts ATP hydrolysis into force within cardiac and slow-skeletal-muscle sarcomeres. Pathogenic variants are major causes of hypertrophic and dilated cardiomyopathy and can also produce inherited skeletal myopathies.
4 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in MYH7 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
ACTN2: Alpha-actinin-2
It crosslinks actin at the sarcomeric Z-disc and organizes mechanical and signaling complexes in cardiac and skeletal muscle. Pathogenic variants can cause hypertrophic, dilated, or other inherited cardiomyopathies and occasional skeletal-muscle phenotypes.
1 ClinVar pathogenic / likely pathogenic and 497 uncertain variants in ACTN2 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
MYBPC3: Myosin-binding protein C, cardiac-type
A cardiac thick-filament protein positioned in the cross-bridge region of striated muscle. It binds myosin and actin and helps tune contraction, while MYBPC3 variants are a leading genetic cause of hypertrophic cardiomyopathy.
1 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in MYBPC3 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
JPH2: Junctophilin-2
It anchors the sarcoplasmic reticulum close to transverse tubules, creating junctional membrane domains required for tightly coupled calcium entry and calcium release in heart muscle. Pathogenic variants can disrupt excitation-contraction coupling and cause hypertrophic or dilated cardiomyopathy and inherited arrhythmia phenotypes.
1 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in JPH2 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
TNNI3: Troponin I, cardiac muscle
It restrains cardiac actin-myosin interaction at low calcium and shifts position within the troponin complex when calcium binds, allowing contraction. Pathogenic variants can alter thin-filament calcium sensitivity and cause hypertrophic, restrictive, or dilated cardiomyopathy.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TNNI3 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
KCNH2: Voltage-gated inwardly rectifying potassium channel KCNH2
Its unusually rapid inactivation and slow deactivation shape the rapid delayed-rectifier current IKr, a major determinant of ventricular repolarization. Loss-of-function variants can prolong repolarization and cause long-QT syndrome, whereas gain-of-function variants can cause short-QT syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNH2 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
MYH6: Myosin-6
Its alpha-myosin motor contributes to ATP-dependent force generation in the cardiac sarcomere, particularly in atrial myocardium. Pathogenic variants can cause cardiomyopathy, congenital heart defects, and selected conduction-system disorders.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in MYH6 have source records linked to Primary familial hypertrophic cardiomyopathy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): LDB3, LMNA, MYL2, RBM20, ACTC1, ANKRD1, CSRP3, DES and 7 more.
ClinVar pathogenic and likely pathogenic variants linked to Primary familial hypertrophic cardiomyopathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GLA R301Q | 301 | Pathogenic / likely pathogenic (★★) | |
| GLA M290T | 290 | Pathogenic / likely pathogenic (★★) | |
| GLA R301G | 301 | Pathogenic / likely pathogenic (★★) | |
| GLA R342Q | 342 | Pathogenic / likely pathogenic (★★) | |
| MYH7 L915P | 915 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| ACTN2 T247M | 247 | Calponin-homology (CH) 2 | Pathogenic / likely pathogenic (★★) |
| GLA A348P | 348 | Pathogenic / likely pathogenic (★★) | |
| MYH7 F252C | 252 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYH7 N444S | 444 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYH7 E848G | 848 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| JPH2 T161K | 161 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| KCNH2 S621N | 621 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| MYBPC3 E542Q | 542 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| TNNI3 R162P | 162 | Pathogenic / likely pathogenic (★★) |
Which prediction tools work for Primary familial hypertrophic cardiomyopathy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- VARITY: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 87 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 85 out of 100
- EVE: 84 out of 100
- SIFT: 82 out of 100
- CADD: 80 out of 100
- phyloP: 76 out of 100
- phastCons: 68 out of 100
Same protein, different disease
- Fabry disease also has ClinVar records linked to GLA variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (320 pathogenic / likely pathogenic).
- Hypertrophic cardiomyopathy also has ClinVar records linked to MYH7 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (239 pathogenic / likely pathogenic).
- Dilated cardiomyopathy also has ClinVar records linked to MYH7 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (21 pathogenic / likely pathogenic).
- Primary dilated cardiomyopathy also has ClinVar records linked to MYH7 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (15 pathogenic / likely pathogenic).
- Hyaline body myopathy also has ClinVar records linked to MYH7 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (13 pathogenic / likely pathogenic).
- Laing early-onset distal myopathy also has ClinVar records linked to MYH7 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (7 pathogenic / likely pathogenic).
- Hypertrophic cardiomyopathy also has ClinVar records linked to MYBPC3 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (19 pathogenic / likely pathogenic).
- Left ventricular noncompaction also has ClinVar records linked to MYBPC3 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (8 pathogenic / likely pathogenic).
- Hypertrophic cardiomyopathy also has ClinVar records linked to TNNI3 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (24 pathogenic / likely pathogenic).
- Familial restrictive cardiomyopathy also has ClinVar records linked to TNNI3 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (11 pathogenic / likely pathogenic).
- Dilated cardiomyopathy 1FF also has ClinVar records linked to TNNI3 variants; they fall mostly in different places as the Primary familial hypertrophic cardiomyopathy variants (7 pathogenic / likely pathogenic).
Diseases related to Primary familial hypertrophic cardiomyopathy
- Hypertrophic cardiomyopathy, also linked to GLA, JPH2, MYBPC3, MYH6 and 2 more
- Primary dilated cardiomyopathy, also linked to ACTN2, MYBPC3, MYH6, MYH7 and 1 more
- Dilated cardiomyopathy, also linked to JPH2, MYBPC3, MYH7 and TNNI3
- Familial isolated dilated cardiomyopathy, also linked to MYH6, MYH7 and TNNI3
- Familial restrictive cardiomyopathy, also linked to MYH7 and TNNI3
- Left ventricular noncompaction, also linked to MYBPC3 and MYH7
- Primary familial dilated cardiomyopathy, also linked to MYH6 and MYH7
- Long QT syndrome, also linked to KCNH2
- Fabry disease, also linked to GLA
- Cardiac arrhythmia, also linked to KCNH2
- Short QT syndrome, also linked to KCNH2
- Atrial septal defect, also linked to MYH6
Frequently asked questions
Which genes have records linked to Primary familial hypertrophic cardiomyopathy?
This view contains 8 analyzed proteins: GLA, MYH7, ACTN2, MYBPC3, JPH2 and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 408 variants of uncertain significance and 130 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 579 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center